Delivery Order SPE2DB22D1052-SPE2DB25FU9WE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,032.75 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 24, 2025, valued at $8,648.10 for Lo Loestrin Fe 1-10 tablets (28-count packages) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-competitive delivery order is set to be completed by July 25, 2025, with the place of performance located in Conshohocken, Pennsylvania. The award represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order from the Defense Logistics Agency (DLA) valued at $3,132.41 for Lo Loestrin Fe 1-10 tablets (28-count package). Awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a larger contract vehicle. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,171.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count units. This is a non-set-aside contract with a completion date of June 3, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.96 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of June 20, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,575.17 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on June 2, 2025, with completion scheduled for June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $3,221.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on September 5, 2025, with completion targeted for September 8, 2025. This contract represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $38,236.07 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lo Loestrin Fe 1/10 tablets in quantities of 28 units. This non-competitive, firm fixed-price delivery order is set to be completed by August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical delivery executed under the company's existing contract vehicle...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9WEDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Lo Loestrin FE 1-10 Tablet 28s with a ceiling value of $5,213.35. The award was made on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's role as a critical supplier to the federal medical procurement system, particularly serving the military and veteran healthcare networks through the DLA's supply chain operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. The company supplies a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, with delivery services performed from the vendor's Conshohocken, Pennsylvania location. The contract reflects the DLA's strategic approach to pharmaceutical procurement through prime vendor arrangements that enable flexible, multi-sourced acquisition of critical medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/15/25 |